On Thursday, Shares of Shire PLC (ADR)(NASDAQ:SHPG), added 1.52% and closed at $189.84 in the last trading session. The last trading range of the stock ranges between $185.98 and $192.64. Shire plc (LSE: SHP, NASDAQ: SHPG) recently will host an Shareholder Day focused on its commercial portfolio and innovative R&D pipeline, counting highlights from its late-stage clinical portfolio, which together support its long term growth aspirations.
“Over the last three years, Shire’s sharp focus has assisted us build an industry leading rare disease pipeline,” said Flemming Ornskov, M.D., M.P.H., Chief Executive Officer. “Our pipeline, which is the most robust in Shire’s history, includes more than 40 clinical programs, over 50% of which are in registration or Phase 3, and 70% of which are in rare diseases. We focus on delivering first- and best- in-class medicines to address noteworthyunmet need for patients around the world to achieve maximum impact.”
Zebra Technologies Corp. (NASDAQ:ZBRA), jumped 1.53% and closed at $68.18 in the last trading session. The last trading range of the stock ranges between $67.55 and $69.68. The company’s Market capitalization is $3.73 Billion with the total Outstanding Shares of 52.77 million. Zebra Technologies Corporation (ZBRA), a global leader in providing solutions and services that give enterprises real-time visibility into their operations, recently declared that its financial statements for the year ended Dec. 31, 2015, and the quarters ended April 2, 2016 and July 2, 2016, will be restated. The Audit Committee of the Board of Directors made the decision upon the recommendation by administration, in consultation with the company’s independent registered public accounting firm, Ernst & Young. The restatement is expected to be accomplished by Nov. 15, 2016, at which time the company will declare its third quarter 2016 earnings results.